Aug 2026· Frontiers in Neuroscience· Vol 20· 0 citations· 92 references
Medicine
TL;DR
It is suggested that therapeutic responses in Crohn’s disease-associated depression may depend on the extent to which interventions modulate distinct components of the GBA, including immune, neural, and microbial pathways.
Abstract
Depression is a highly prevalent and clinically significant comorbidity in Crohn’s disease (CD), a form of inflammatory bowel disease (IBD), and is associated with increased disease activity, hospitalization, and a reduced quality of life (QoL). While traditionally attributed to the psychosocial burden of chronic illness, emerging evidence indicates that depressive symptoms in CD arise from dysregulation of the gut-brain axis (GBA), a bidirectional network linking immune, microbial, and central nervous system (CNS) processes. Chronic intestinal inflammation, characterized by elevated cytokines such as tumor necrosis factor (TNF-α) and interleukin-6 (IL-6), may influence brain function through vagal signaling, hypothalamic-pituitary-adrenal (HPA) axis activation, and neuroimmune pathways. Concurrently, epithelial barrier dysfunction and microbial dysbiosis promote translocation of bacterial products, further amplifying systemic inflammation and neuroimmune signaling. This review consolidates preclinical and clinical evidence linking immune activation, microbial alterations, and neuroimmune signaling to depression in CD. The review compares emerging therapeutic strategies, such as ketamine enantiomers, vagus nerve stimulation, and microbiota-targeting natural compounds, with established therapies like serotonergic antidepressants, cognitive behavioral therapy, and biologic immunotherapies. Across these modalities, therapeutic effects on mood are heterogeneous and often dissociated from improvements in intestinal inflammation, highlighting the multifunctional nature of GBA dysfunction. Overall, these findings suggest that therapeutic responses in CD-associated depression may depend on the extent to which interventions modulate distinct components of the GBA, including immune, neural, and microbial pathways. These observations emphasize the need for integrative treatment strategies that address the multiple contributors of GBA dysbiosis. Future studies incorporating standardized and emerging psychiatric, immunological, and microbiome outcomes will be critical to identifying mechanisms for specific treatment responses in this population.
Global health challenges associated with neurodegenerative disorders are increasing, prompting growing interest in the gut-brain axis (GBA) as a key contributor to disease pathogenesis. The GBA represents a bidirectional communication network linking the gut microbiota, immune signalling pathways, metabolic processes,...
Riddhi Upadhyay, Chandhini C., Susmita Kar et al.· Frontiers in microbiomes· 0 citations
Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder of the gastrointestinal tract that is frequently associated with neuropsychiatric comorbidities, such as anxiety, depression, and other neurological disorders. Accumulating evidence suggests that these neuropsychiatric disorders are secondary condit...
Bing-Chan Sun, Guo-Xin Wang, Xiao-Xiao Li et al.· Journal of Neurogastroentero...· 0 citations
This narrative review synthesized evidence on the bidirectional relationship between systemic inflammation and psychiatric comorbidities, drawing from 32 peer-reviewed studies, indicates that endometriotic lesions release interleukin-6 and Tumor Necrosis Factor-alpha into systemic circulation, driving chronic immune ac...
D. I. Oraekei, Ogbonnaya Mba, O. Obidiegwu et al.· Advanced Pharmaceutical and...· 0 citations
Parkinson’s disease (PD) is increasingly understood as a multisystem disorder in which gastrointestinal dysfunction, immune remodeling, protein aggregation, and central neurodegeneration interact across the disease course. Although gut microbiota alterations are repeatedly reported in PD, taxonomic differences alone do...
Ming X. Tang, Jing-Xian Li, Chuan Zhang et al.· Frontiers in Aging Neuroscie...· 0 citations
The brain-gut-microbiome system is an integrated communication network linking the central nervous system, enteric nervous system, immune pathways, and intestinal microbiota. Increasing evidence indicates that dysregulation of this bidirectional signaling system contributes to both gastrointestinal and psychiatric diso...
Lin Chang, N. Freimer, E. Hsiao· Annual Review of Physiology· 0 citations
Memory impairment and broader cognitive decline emerge gradually in Alzheimer’s disease (AD), although amyloid-β deposition, tau abnormalities, and neuroinflammatory changes often develop well before the clinical picture is fully established. Drug therapy can lessen selected symptoms, but it does not prevent continuing...
Yu-Jie Gao· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.